Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02500563 · ClinicalTrials.gov registry record · NA
Exploratory/Proof of Principle Microbiota Study
A NA study, sponsored by Mead Johnson Nutrition.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT02500563: Completed NA study, sponsored by Mead Johnson Nutrition.
NCT02500563 is a NA study that has completed, run by Mead Johnson Nutrition. The registered enrollment target is 78 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02500563, a NA study, has completed, sponsored by Mead Johnson Nutrition.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
This clinical trial will evaluate the stool of infants fed one of two infant formulas, which contain different types of proteins, or breast milk to determine if different proteins have an effect on the type of bacteria that enters and lives in an infant's intestine early in life.
Primary Outcome
Sequencing and composition of samples
Interventions
- OTHER Amino acid based infant formula
- OTHER Extensively hydrolyzed casein infant formula
- OTHER Mother's own breast milk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2015-07 |
| Est. Completion | 2017-07 |
| Phase | NA |
What the finished NCT02500563 record still lists
NCT02500563 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Amino acid based infant formula is the first listed.
NCT02500563 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02500563 about?
NCT02500563 is a clinical study titled "Exploratory/Proof of Principle Microbiota Study". This clinical trial will evaluate the stool of infants fed one of two infant formulas, which contain different types of proteins, or breast milk to determine if different proteins have an effect on the type of bacteria that enters and lives in an infant's intestine early in life.
What is the current status of trial NCT02500563?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2015-07. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02500563?
The interventions under investigation include: Amino acid based infant formula (OTHER), Extensively hydrolyzed casein infant formula (OTHER), Mother's own breast milk (OTHER).
Who is sponsoring clinical trial NCT02500563?
This trial is sponsored by Mead Johnson Nutrition, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02500563's enrollment target sits among peer trials
78 1060th of 2000 higher than 939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia